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TACKGROUND& AIMS:Hypoxia inducible factor (HIF)
rolyl hydroxylase inhibitors are protective in mouse
odels of inflammatory bowel disease (IBD). Here, we
nvestigated the therapeutic target(s) and mechanism(s)
nvolved. METHODS: The effect of genetic deletion of
ndividual HIF-prolyl hydroxylase (PHD) enzymes on the
evelopment of dextran sulphate sodium (DSS)–induced
olitis was examined in mice. RESULTS: PHD1/, but
ot PHD2/ or PHD3/, mice were less susceptible to
he development of colitis than wild-type controls as
etermined by weight loss, disease activity, colon histol-
gy, neutrophil infiltration, and cytokine expression. Re-
uced susceptibility of PHD1/ mice to colitis was as-
ociated with increased density of colonic epithelial cells
elative to wild-type controls, which was because of de-
reased levels of apoptosis that resulted in enhanced
pithelial barrier function. Furthermore, with the use of
ultured epithelial cells it was confirmed that hydroxylase
nhibition reversed DSS-induced apoptosis and barrier
ysfunction. Finally, PHD1 levels were increased with
isease severity in intestinal tissue from patients with
BD and in colonic tissues from DSS-treated mice. CON-
LUSIONS: These results imply a role for PHD1 as a
ositive regulator of intestinal epithelial cell apopto-
is in the inflamed colon. Genetic loss of PHD1 is
rotective against colitis through decreased epithelial
ell apoptosis and consequent enhancement of intes-
inal epithelial barrier function. Thus, targeted PHD1
nhibition may represent a new therapeutic approach
n IBD.
eywords: Colitis; Hydroxylase; Apoptosis; Hypoxia.
rolyl hydroxylases (PHDs) are members of a large
family of dioxygenases, a subset of which play a key
ole in intracellular oxygen-sensing and signaling re-
ponses during hypoxia, primarily by the regulation of
he stability of the hypoxia inducible factor (HIF).1–4
hree PHD enzymes that confer oxygen sensitivity to the
IF pathway have been described (PHD1–3).5,6 Although
hese isoforms share similar biochemical characteristics,
hey have distinct tissue-specific expression profiles and,s well as regulating HIF, can also affect prosurvival
ignaling pathways, including nuclear factor B.1,7–10
PHDs mediate their effects on HIF through (oxygen-
ependent) hydroxylation of key proline residues on the
xygen-dependent degradation domain of HIF sub-
nits. When hydroxylated at these sites, HIF becomes a
arget for ubiquitylation by the von Hipple Lindau E3
biquitin ligase leading to HIF ubiquitination and deg-
adation. The specific targets for PHDs in the NF-B
athway remain to be determined, although IKK and
KK contain surface-expressed consensus sites in their
egulatory domains.11 PHDs play a central role in the
daptive response to hypoxia through activation of these
athways with the subsequent expression of genes pro-
oting cell survival, erythropoiesis, angiogenesis, and
etabolism. As such, PHDs may be an effective target for
herapeutic manipulation.1,12 It has recently become clear
hat hydroxylase activity can affect the development of
nflammation and that hydroxylase inhibitors may rep-
esent a novel therapeutic approach in chronic inflam-
atory disease.12,13
Inflammatory bowel disease (IBD) is a genetically het-
rogenous, chronic inflammatory condition with severe
athology and limited therapeutic options.14–16 Al-
hough the underlying causes of IBD remain largely un-
efined, the fundamental defect involves a loss of intes-
inal epithelial barrier function. We and others have
hown that pan-hydroxylase inhibitors such as dimethyl-
xalylglycine (DMOG) have a protective effect in murine
odels of colitis and thus represent a potential new
herapeutic approach.17,18 However, those studies did not
Abbreviations used in this paper: DMOG, dimethyl-oxalylglycine;
SS, dextran sulphate sodium; FITC, ﬂuorescein isothiocyanate; HIF,
ypoxia inducible factor; IL-1, interleukin-1 ; PBS, phosphate-buff-
red saline; PHD, prolyl hydroxylase; siRNA, short interfering RNA;
EER, transepithelial electrical resistance; TUNEL, terminal deoxynu-
leotidyl transferase–mediated deoxyuridine triphosphate nick-end la-
eling.
© 2010 by the AGA Institute
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2094 TAMBUWALA ET AL GASTROENTEROLOGY Vol. 139, No. 6dentify which hydroxylase isoforms or effector pathways
re involved.
Mice lacking individual PHD enzymes have distinct
henotypes. PHD1/ mice show a reprogrammed basal
etabolic profile that decreases muscle performance in
ealthy tissue but provides acute protection in muscle
nd liver ischemia.19,20 PHD2/ mice are embryonic le-
hal with a massive vascular defect during embryogene-
is,21 whereas heterozygous (/) mice show enhanced
umor angiogenesis but decreased metastatic events
hrough what has been termed “endothelial normaliza-
ion.”22,23 PHD3/ mice have reduced neuronal apopto-
is, abnormal sympathoadrenal development, and re-
uced blood pressure.24 The diverse phenotypes in mice
ith different PHD gene deletions strongly suggest that
here are distinct isoform-specific functions for the vari-
us PHD enzymes in vivo.
To develop our understanding of the mechanisms of
rotection of pan-hydroxylase inhibitors in colitis, we
nvestigated disease development in PHD1-, PHD2-, and
HD3-deficient mice exposed to dextran sulphate so-
ium (DSS) in their drinking water to induce colitis. We
ound that PHD1/, but not PHD2/ or PHD3/,
ice, were selectively protected against the development
f colitis. This protection was associated with enhanced
ntestinal epithelial barrier function which was due to
iminished epithelial cell apoptosis. These data implicate
positive role for PHD1 in the regulation of intestinal
pithelial cell apoptosis during intestinal inflammation
nd strengthen the case for the development of PHD1-
pecific inhibitors targeted to intestinal epithelial cells as
new therapeutic approach in the treatment of IBD.
Materials and Methods
Animals
PHD1/, PHD2/, and PHD3/ mice against
mixed background strain of Swiss/129, which were
sed for these experiments have been previously de-
cribed.19,23,24 None of the PHD knockout mice showed
ifferential weight gain compared with wild-type mice.
DSS Colitis Model
The DSS model of colitis was used as described
reviously.17 Briefly, acute disease was induced by the
reatment of mice with 5% DSS in their drinking water
or 6 days. The disease activity index was determined
ccording to the parameters outlined in Supplementary
able 1.25,26 On termination of the experiment, mice were
illed by cervical dislocation, and colonic tissues were
issected for further analysis. All procedures described
ere approved by the relevant institutional Animal Re-
earch Ethics Committee.
Assessment of Tissue Inflammation
Small (approximately 1 cm) sections of excisedolonic tissue were fixed in 10% paraformaldehyde (pH, h.4; phosphate-buffered saline [PBS] buffered) and em-
edded in paraffin. Sections (4 m) were cut and stained
ith H&E. Histologic assessment of colonic mucosae was
arried out in a blinded fashion as described in Supple-
entary Table 2.26 To assay for markers of inflammation,
olonic tissues were homogenized, and levels of tumor
ecrosis factor-, interleukin-1 (IL-1), IL-6, and myelo-
eroxidase were measured as described previously.17
Western Blotting
Whole colon tissues were thawed, homogenized,
onicated in standard Western blotting lysis buffer, and
igorously stirred until a vortex formed before centrifu-
ation at 12,000 rpm for 5 minutes. Supernatant was
emoved and normalized to 1 g/L and separated by
odium dodecyl sulfate–polyacrylamide gel electrophore-
is as described previously.17 After transfer to nitrocellu-
ose membranes, PHD1 was detected by Western blot
ith the use of an anti-PHD1 primary antibody (Novus
iologicals, Littleton, CO).
In Vivo Permeability Assay
Mice were exposed to 6 days of DSS treatment
efore oral administration of 0.6 mg/g of body weight
uorescein isothiocyanate (FITC)–labeled dextran (4
Da) by standard oral gavage. Mice were killed 3.5 hours
ater, and blood was removed by cardiac puncture.
lasma was separated, and FITC levels in the plasma were
etermined by fluorometry. The distribution of FITC-
extran in sectioned colonic tissue was determined by
uorescence microscopy.
In Vitro Permeability Assay
CaCo-2 epithelial cells (passage 19–26) were
eeded on uncoated 6.5-mm semipermeable (3.0-m
ore) Transwell polycarbonate membranes (Costar, Cam-
ridge MA). Monolayers were maintained for 4–5 weeks
efore experimentation to ensure an efficient barrier
nd development of transepithelial electrical resistance
TEER). Cells were cotreated with DMOG 1 mmol/L (or
imethyl sulfoxide vehicle) and 4% DSS (wt/vol; in Dul-
ecco’s modified Eagle medium supplemented with 10%
etal calf serum and penicillin/streptomycin) in the apical
nd basolateral compartments of the Transwell mem-
rane. TEER values were obtained with the use of a
EMS Autosampler (World Precision Instruments, Sara-
ota, FL) at the indicated time points. Values are indica-
ive of triplicate wells per treatment for 4 independent
assage numbers.
Immunohistochemistry
Sections (4 m) were cut from the paraffin blocks,
eparaffinized with xylene, and rehydrated in a graded
eries of alcohols. For immunohistochemical staining,
ndogenous peroxidase activity was quenched with 3%
ydroxen peroxide solution for 10 minutes. Antigen re-
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December 2010 PHD1 LOSS IS PROTECTIVE IN COLITIS 2095rieval was performed by immersing the slides in protein-
se K solution (20 g/mL in 10 mmol/L Tris-HCl, pH
.5) for 12 minutes. Sections were blocked with 5% goat
erum for 1 hour at room temperature and then incu-
ated overnight with primary antibody at 4°C in a hu-
idified chamber. The primary antibodies used were rab-
it anti–KI-67 (1:100 dilution; Abcam, Cambridge,
nited Kingdom), rabbit anti-cleaved caspase-3 (Asp175;
:200 dilution; Cell Signaling Technology, Danvers, MA),
nd rabbit anti–cytokeratin 8 (1:100 dilution; Abcam).
he slides were then treated with biotinylated goat anti–
abbit antibody (1:200 dilution; Vector Laboratories, Pe-
erborough, United Kingdom). ABC immunodetection
VECTASTAIN Elite ABC Kit; Vector Laboratories) was
sed to detect cleaved caspase 3 and KI-67. The sections
ere developed with diaminobenzidine as a chromagen
nd counterstained with hematoxylin. Cytokeratin 8 was
etected with avidin-conjugated Texas red (1:50 dilution;
erck Biosciences, Darmstadt, Germany) followed by
uclear counterstain with Hoechst 33342 dye. PBS/1%
ween solution was used to wash sections between steps.
olonic sections from 5 to 7 animals were stained for
I-67, cytokeratin 8, or cleaved caspase 3. In the case of
I-67 and cleaved caspase 3, for each section, three 200
r 400 fields, respectively, were randomly selected, and
he number of positive cells per 100 enterocytes was
uantified. All scoring was carried out in a blinded fash-
on.
Terminal Deoxynucleotidyl
Transferase–Mediated Deoxyuridine
Triphosphate Nick-End Labeling Stain
Cellular apoptosis was identified with terminal
eoxynucleotidyl transferase–mediated deoxyuridine
riphosphate nick-end labeling (TUNEL; Fluorescein In
itu Cell Death Detection Kit; Roche Diagnostic, Mann-
eim, Germany). After de-waxing, rehydration and pro-
einase K antigen retrieval colon sections were incubated
ith the TUNEL reaction mix for 1 hour at 37°C in a
umidified chamber. Sections were counterstained with
oechst dye and analyzed with fluorescent microscopy.
olonic sections from 5 animals per group were TUNEL
tained. For each section, three 400 fields were ran-
omly selected, and the number of positive cells per 100
nterocytes was quantified. All scoring was carried in a
linded fashion.
In Vitro Apoptosis Assay
CaCo-2 cells were treated with DMOG (1 mmol/L,
4 hours) or transfected with 50 nmol/L PHD1 short
nterfering RNA (siRNA) or control nontarget siRNA
Dharmacon, Lafayette, CO). Transfections were carried
ut with Lipofectamine 2000 (Invitrogen, Paisley, United
ingdom). After treatment, cells were treated with DSS
1%, 24 hours). The cells were harvested, resuspended in
ce-cold PBS, and incubated with YO-PRO-1, Hoechst
3342, and propridium iodide (Vybrant Apoptosis Assay mit #7; Invitrogen) according to the manufacturer’s pro-
ocol. Flow cytometric analyses were carried out with the
yAn ADP analyser (Beckman Coulter, Fullerton, CA)
nd Summit 4.3 software. Cells were defined as living,
arly apoptotic, or late apoptotic/necrotic according to
heir relative dye uptake.
Statistical Analysis
Statistical comparisons were made by analysis of
ariance or Student t test. Values are expressed as mean
EM for n individual experiments.
Results
PHD1-Deficient Mice Are Protected Against
DSS-Induced Colitis
Previous studies have shown that treatment with
an-hydroxylase inhibitors is protective in DSS-induced
olitis in mice.17,18 Those studies used broad-spectrum
ydroxylase inhibitors such as DMOG because pharma-
ologic isoform-specific inhibitors are currently un-
vailable. To determine which PHD enzyme or multiple
nzymes are responsible for the protective effects of pan-
ydroxylase inhibition, we investigated the development
f DSS-induced colitis in PHD1/, PHD2/, and
HD3/ mice. We found that only PHD1/ mice were
ignificantly protected from DSS-induced colitis as de-
ermined by weight loss (Figure 1A) and disease activity
ndex measurements (Figure 1B). PHD1/mice also had
ignificantly attenuated histologic signs of inflammation
ompared with wild-type controls (Figure 1C and D). The
educed severity of DSS-induced colitis in PHD1/ mice
as confirmed by the significantly lower levels of myelo-
eroxidase enzymatic activity, a marker of neutrophil
nfiltration, in the colons of PHD1/ mice relative to
ild-type animals (Figure 1E). Furthermore, the levels of
SS-induced inflammatory cytokines, including IL-1,
umor necrosis factor- and IL-6, were significantly lower
n PHD 1/ mice than in wild-type controls (Figure 1E).
n contrast, PHD2/ and PHD3/ mice did not show
ttenuated DDS-induced inflammation in all parameters
nvestigated (data not shown). Taken together, these data
ndicate that PHD1/ mice are selectively protected
gainst the development of colitis.
Increased Enterocyte Density in
PHD-Deficient Mice in Colitis
We next carried out high magnification (400)
icroscopic analysis of mucosal structure in wild-type
nd PHD1/ mice exposed to DSS. Increased intestinal
pithelial cell density was observed in PHD1/ mice
reated with DSS compared with wild-type controls (Fig-
re 2A). The insets in Figure 2A represent high magnifi-
ation areas of intestinal epithelial cells showing in-
reased epithelial density in colonic tissues derived from
SS-treated PHD1/ mice compared with wild-type
ice. The enhanced epithelium was confirmed by epithe-
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2096 TAMBUWALA ET AL GASTROENTEROLOGY Vol. 139, No. 6ial-specific cytokeratin staining in colonic tissues (Figure
B), which shows decreased ulceration in DSS-treated
HD1/mice compared with wild-type controls. Collec-
ively, these data led us to hypothesize that the protective
ffects of PHD1 deficiency were due to enhanced epithe-
ial barrier function as a result of increased intestinal
pithelial cell density.
Enhanced Epithelial Barrier Function in
PHD1/ Mice
To further address the effects of loss of PHD1 on
he intestinal epithelial barrier, in vivo intestinal barrier
unction was measured in wild-type and PHD1/ mice
xposed to DSS. Mice were given an oral dose of FITC-
extran on the final day of DSS exposure, and 4 hours
ater FITC levels in the plasma were determined as a
easure of intestinal permeability. Although DSS in-
uced a characteristic increase in intestinal permeability
s reflected by increased appearance of FITC in plasma,
his was markedly diminished in PHD1/ mice (Figure
igure 1. PHD1/ mice are selectively protected against DSS-induc
HD1/, PHD2/, or PHD3/ mice exposed to 5% DSS. (B) Diseas
ice exposed to DSS (). (C) Representative 100 histologic images a
ild-type or PHD1/mice (scale bar 100m). (E) Myeloperoxidase (M
n wild-type and PHD1/ mouse colonic tissue 6 days after initiation
inimum of 6 individual mice. *P  .05; **P  .01; nsd, not significantA). Furthermore, fluorescent microscopic detection of tITC in colonic tissues from these animals showed re-
ention of FITC at the epithelial barrier in PHD1/
ice, whereas in wild-type mice FITC had transcended
he epithelial barrier (Figure 3B).
To test whether hydroxylase inhibition can directly
ffect epithelial barrier function, we next exposed cul-
ured intestinal epithelial cells (CaCo-2), grown on per-
eable support inserts to increasing periods of DSS and
easured barrier disruption by measuring TEER. Cells
reated with the hydroxylase inhibitor DMOG showed
educed barrier dysfunction compared with cells treated
ith vehicle and DSS alone, indicating that hydroxylase
nhibition in isolated enterocytes confers resistance to
SS-induced barrier dysfunction (Supplementary Figure
). Taken together, these data indicate that loss of PHD1
eads to enhanced epithelial barrier function in colitis.
Decreased Enterocyte Apoptosis in PHD1/
Mice Exposed to DSS
We next investigated whether the increase in en-
litis. (A) Weight change measurements over 6 days in wild-type (WT),
ivity indices over 6 days in wild-type, PHD1/, PHD2/, or PHD3/
) histologic scores of colonic tissue taken from control and DSS-treated
tumor necrosis factor- (TNF), IL-1, and IL-6 levels were determined
ministrating DSS. Each control and experimental group contained a
rent; L, lumen.ed co
e act
nd (D
PO),
of aderocyte density (Figure 2) and enhanced barrier function
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December 2010 PHD1 LOSS IS PROTECTIVE IN COLITIS 2097Figure 3) observed in PHD1/ mice was due to de-
reased epithelial cell death or increased proliferation.
mmunohistochemical KI67 staining (a marker of prolif-
rating cells) was not different between wild-type and
HD1/ mice either with or without DSS treatment,
ndicating no difference in proliferation between groups
Figure 4A).
We next investigated intestinal epithelial cell apoptosis
ith the use of both TUNEL staining and detection of
leaved caspase 3. Basal rates of apoptosis detected with
oth techniques were similar in PHD1/ and wild-type
igure 2. Increased epithelial density in homozygous PHD1 knockout
ice exposed to DSS. (A) High magnification (400) histologic images
f colonic tissue from wild-type (WT) and PHD1/ mice with and with-
ut DSS treatment shows increased intestinal epithelial density in tis-
ues from PHD1/ animals (scale bar 25m). Insets show examples
f areas of epithelium in high magnification (1600). L, lumen; U, region
f ulceration. (B) Immunohistochemical analysis (200) of cytokeratin
staining red) and nuclei (staining blue) in colonic tissue from wild-type
nd PHD1/ mice with DSS treatment shows increased mucosal ul-
eration and decreased epithelial density in wild-type mice compared
ith PHD1/mice (scale bar 50m). Each control and experimental
roup contained a minimum of 6 individual mice (L, lumen; U, area of
lceration).ice. However, PHD1/ mice exhibited a significantly (ower degree of enterocyte apoptosis when exposed to
SS than did wild-type mice (Figure 4B and C). Collec-
ively, these data indicate that PHD1/ mice are resis-
ant to DSS-induced colitis because of barrier-protective
ffects associated with decreased enterocyte apoptosis.
To investigate whether PHD1 inhibition could directly
ffect epithelial apoptosis, cultured enterocytes were ex-
osed to DSS in the presence and absence of the pan
ydroxylase inhibitor DMOG or siRNA targeted to
HD1, and the induction of early and late apoptosis was
easured. DMOG (Figure 5A) or PHD1 siRNA (Figure
B) significantly inhibited DSS-induced apoptosis in iso-
ated enterocytes, indicating a direct antiapoptotic effect
f pharmacologic hydroxylase inhibition on epithelial
ells.
igure 3. Enhanced epithelial barrier function in PHD1/ mice.
A) Intestinal permeability was measured by the appearance of orally
dministered FITC-labeled dextran in plasma from wild-type and
HD1/ mice exposed to DSS (bars represent mean SEM; *P .5;
 6). (B) Fluorescence microscopy (100) of the intestinal mucosa
rom DSS-treated wild-type (WT) and PHD1/ mice exposed to orally
dministered FITC-labeled dextran shows FITC permeation into tissue
s enhanced in wild-type animals treated with DSS compared with
HD1/ animals whereby FITC-dextran is retained at the epithelium
scale bar  100 m) L, lumen.
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2098 TAMBUWALA ET AL GASTROENTEROLOGY Vol. 139, No. 6PHD1 Expression Is Correlated With Disease
Severity in Patients With IBD
Having identified PHD1 as a potential target for
harmacologic intervention in IBD, we next examined
he expression of PHD1 in intestinal tissue taken from
atients undergoing restorative proctocolectomy for sur-
ical treatment of IBD. Intestinal tissues from patients
ith IBD were independently scored by 2 clinical pathol-
gists and categorized for histopathologic grade of in-
ammation according to the Truelove and Richards
cale27 (grade 0, no inflammation; grade 1, chronic inac-
ive inflammation [increased content of mononuclear
ells within the mucosal lamina propria]; grade 2, mild
ctive inflammation [plus few circumscript foci with neu-
rophilic intraepithelial infiltrates/cryptitis or single
rypt abscesses]; grade 3, moderate active inflammation eplus several foci with neutrophilic intraepithelial infil-
rates/cryptitis or crypt abscesses]). Semiquantitative analy-
is of immunoblots showed significantly higher expression
f PHD1 protein in colon samples that displayed active
ucosal inflammation (Figure 6A and B). Indeed, PHD1
as relatively overexpressed in 100% of tissue samples dis-
laying high inflammatory activity (Truelove and Richards
core 2–3). By contrast, relative overexpression of PHD1 was
nly observed in 33% of samples with inactive inflammation
Truelove and Richards score 0–1). This difference was sig-
ificant when applying the Fisher’s exact test (P .015; n
). Similarly, colonic tissue from mice showed increased
HD1 expression after DSS exposure (Supplementary Fig-
re 2). In summary, although PHD deficiency or inhibition
s associated with decreased disease activity, increased PHD
Figure 4. Decreased enterocyte
apoptosis in PHD1/ mice ex-
posed to DSS. (A) Representative
100 immunohistochemical im-
ages (left) and quantification of in-
testinal epithelial cell proliferation
(right) in wild-type (WT) and
PHD1/ mice exposed to DSS
as measured by KI-67 staining
(scale bar  50 m). (B) Repre-
sentative 100 immunofluores-
cence images (left) and quantifica-
tion of intestinal epithelial cell
apoptosis (right) in wild-type and
PHD1/ mice exposed to DSS
as measured by TUNEL staining
(scale bar  50 m). (C) Repre-
sentative 200 immunohisto-
chemical images (left) and quanti-
fication of intestinal epithelial cell
apoptosis (right) in wild-type and
PHD1/ mice exposed to DSS
as measured by cleaved
caspase-3 staining (scale bar 
25 m). Each control and experi-
mental group contained a mini-
mum of 6 individual mice. *P 
.05.xpression is associated with disease severity.
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December 2010 PHD1 LOSS IS PROTECTIVE IN COLITIS 2099Discussion
A common feature of all IBD regardless of the
nderlying cause is the loss of intestinal epithelial barrier
unction because of excessive epithelial cell death, an
vent that allows the nonspecific movement of luminal
ntigenic material into the submucosa.28 The resulting
igure 5. PHD1 inhibition blocks apoptosis in cultured enterocytes.
A) CaCo-2 intestinal epithelial cells were exposed to 1% DSS or vehicle
or 24 hours with and without pretreatment with DMOG (1 mmol/L).
umbers of live and apoptotic epithelial cells were determined by flow
ytometric analysis. (B) CaCo-2 cells were exposed to siRNA directed
gainst PHD1. Specific siRNA treatment resulted in effective knock-
own of PHD1 (top) and resulted in decreased numbers of DSS-in-
uced apoptotic cells (bottom). Data shown reflect a minimum of 4
ndividual experiments. *P  .05; **P  .01.nflammatory response drives further barrier dysfunction und the symptoms associated with the disease, thus es-
ablishing a positive feed forward loop between develop-
ng inflammation and barrier dysfunction. The intestinal
pithelial barrier relies heavily on the controlled turnover
f intestinal epithelial cells, which originate from stem
ells in the intestinal crypts and migrate to the top of the
rypt or villus before undergoing apoptosis and being
eleased into the intestinal lumen. The regulation of the
ntestinal epithelial cell turnover is a complex balance
etween epithelial proliferation and cell death in which
tem cells play a key role.29 In the physiologic state,
ntestinal epithelial cells have a relatively short life span,
nd their programmed cell death through apoptosis is a
arefully controlled process that is probably critical for
he maintenance of normal barrier function.30 The regu-
atory factors that are responsible for the initiation of
hysiologic intestinal epithelial cell apoptosis remain to
e fully elucidated; however, increased rates of apoptosis
ith resultant dysfunction of the intestinal epithelial
arrier is central to the pathology of IBD.31 Thus, ther-
pies directed toward delaying or suppressing intestinal
pithelial cell apoptosis may allow time for mucosal heal-
ng to occur in IBD and may thus represent a therapeutic
pproach.
We, and others, have demonstrated that pan hydroxy-
ase inhibition is protective against the development of
igure 6. PHD1 levels correlate with inflammatory score in patients
ith IBD. (A) Representative immunoblots of colon tissues from patients
ith ulcerative colitis with either inactive (left) or active (right) mucosal
nflammation. Equal amounts of protein were loaded. (B) Densitometric
nalysis of PHD1 protein concentrations in colon mucosa from patients
ith inactive (Truelove and Richards score 0–1) or active mucosal in-
ammation (score 2–3), normalized to the expression of -actin. Bars
epresent mean  SEM of relative band intensity values (a.u., arbitrary
nits). *P  .05; n  8.
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2100 TAMBUWALA ET AL GASTROENTEROLOGY Vol. 139, No. 6olitis in multiple models.17,18 In the current study, we
nd that PHD1/ mice selectively show a significant
ecrease in DSS-induced apoptosis, an event that we
ypothesize to be linked to enhanced barrier function
nd subsequent protection against the development of
olitis. This is supported by studies that investigated the
ink between hydroxylase activity and apoptosis in other
odel systems, which have shown an antiapoptotic effect
f pharmacologic hydroxylase inhibition.32–34
Hydroxylase inhibition affects multiple transcriptional
athways, including HIF and NF-B, both of which have
een shown to be protective in epithelial cells during
BD.35 HIF activates the expression of a range of factors,
ncluding intestinal trefoil factor, CD73, and the adeno-
ine A2B receptor that have been shown to be barrier
rotective.35 Furthermore, NF-B activation results in
ncreased expression of antiapoptotic factors.36 We have
roposed that the combined effects of barrier protective
nd antiapoptotic gene expression in epithelial cells,
hich occurs by these pathways, underpin the effective-
ess of pan-hydroxylase inhibitors in models of IBD.35 In
he current study, we have identified that PHD1 is the
ey target hydroxylase in mediating the protective effects
f hydroxylase inhibitors in colitis and thus represents a
ikely therapeutic target for IBD. Importantly, because of
he lethality of a homozygous PHD2 knockout mouse,
e cannot rule out a possible role for a protective effect
f complete PHD2 inhibition during colitis. Future stud-
es will determine whether the protection afforded by
ydroxylase inhibition is by activation of HIF, NF-B, or
ther transcriptional regulators. Increased PHD1 corre-
ates with disease severity in patients with IBD, reflecting
positive relationship between the expression levels of
HD1 and disease severity. In a previous study, Robinson
t al18 demonstrated that PHD isoform mRNA expres-
ion levels in the intestinal mucosa were in the order
HD2  PHD3  PHD1. Although the mRNA expres-
ion levels of PHD1 are lowest in noninflamed tissue, we
ound that PHD1 levels were increased in inflamed tis-
ues from patients with IBD, raising the intriguing pos-
ibility that increased PHD1 expression or activity may be
ontributing to disease progression through increasing
pithelial cell apoptosis and reducing barrier function. In
ummary, we propose that, as a positive regulator of
ntestinal epithelial cell apoptosis in colitis, PHD1 repre-
ents a new therapeutic target in the treatment of inflam-
atory bowel disease.
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